Results 61 to 70 of about 11,454,093 (341)

Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes

Cardiovascular Diabetology, 2018
BackgroundType 2 diabetes mellitus (T2DM) greatly increases the risks of cardiovascular disease and heart failure. In particular, left ventricular diastolic dysfunction that develops from the early stages of T2DM is an important factor in the onset and ...
Daisuke Matsutani, Masaya Sakamoto, Y. Kayama, Norihiko Takeda, Ryuzo Horiuchi, K. Utsunomiya   +5 more
semanticscholar   +1 more source

Quantity and Volume of Perivascular Spaces Are Inversely Associated With Multiple Sclerosis Relative to Cerebrovascular Disease and Migraine

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To quantify the number and volume of whole brain perivascular spaces (PVS) using a detection and segmentation algorithm in participants with multiple sclerosis (MS) and patients with disorders mimicking MS known to potentially influence PVS, such as cerebrovascular disease.
Elle M. Levit, Elizabeth A. Horwath, Daniel L. Schwartz, Lisa C. Silbert, Russell T. Shinohara, Andrew J. Solomon   +5 more
wiley   +1 more source

Influência da redução da pré-carga sobre o índice de desempenho miocárdico (índice de Tei) e outros parâmetros Doppler ecocardiográficos da função ventricular esquerda Influence of preload reduction on Tei index and other Doppler echocardiographic parameters of left ventricular function

Arquivos Brasileiros de Cardiologia, 2006
OBJETIVO: Avaliar os efeitos da redução da pré-carga induzida por uma sessão de hemodiálise sobre o índice de desempenho miocárdico (Tei) e outros parâmetros ecocardiográficos de função cardíaca.
Silvio Henrique Barberato, Roberto Pecoits Filho   +1 more
doaj   +1 more source

Autonomic regulation therapy to enhance myocardial function in heart failure patients: the ANTHEM-HFpEF study. [PDF]

, 2017
BackgroundApproximately half of the patients presenting with new-onset heart failure (HF) have HF with preserved left ventricular ejection fraction (HFpEF) and HF with mid-range left ventricular ejection fraction (HFmrEF).
Amurthur, Badri, Anand, Inder S, Ardell, Jeffrey L, DiCarlo, Lorenzo A, KenKnight, Bruce H, Kumar, H Uday, Libbus, Imad, Mittal, Sanjay, Premchand, Rajendra K   +8 more
core   +1 more source

The Diverse Neuromuscular Spectrum of VPS13A Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective VPS13A disease (chorea‐acanthocytosis) is a rare neurodegenerative disorder caused by biallelic variants in VPS13A, typically presenting with hyperkinetic movement disorders, while neuromuscular signs are often mild. The aim of the project was to investigate the frequency and severity of neuromuscular impairment in VPS13A disease ...
Anne Buchberger, Evamaria Riedel, Marie Hackenberg, Alexander Mensch, Stefanie Beck‐Woedl, Joohyun Park, Tobias B. Haack, Bernhard Haslinger, Jan Kirschke, Holger Prokisch, Andreas Hermann, Christian Mawrin, Adrian Danek, Benedikt Schoser, Kevin Peikert, Marcus Deschauer, Isabell Cordts   +16 more
wiley   +1 more source

Efeitos da angiotensina-I e isquemia na recuperação funcional em corações isolados Effects of angiotensin-I and ischemia on functional recovery in isolated hearts

Arquivos Brasileiros de Cardiologia, 2011
FUNDAMENTO: A ressuscitação de parada cardíaca pode apresentar disfunção miocárdica determinada pelo tempo da isquemia, e a inibição da enzima conversora de angiotensina (ECA) pode reduzir a disfunção cardíaca durante a reperfusão.
Ubirajara Oliveira de Oliveira, Álvaro Reischak de Oliveira, Luiz Carlos Kucharski, Ubiratan Fabres Machado, Maria Claudia Irigoyen, Beatriz D'Agord Schaan   +5 more
doaj  

Growth Differentiation Factor 15 Elevation in the Central Nervous System Is Associated With Failure to Thrive in Alexander Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Alexander disease (AxD) is a severe neurodegenerative disorder caused by gain‐of‐function mutations in the gene for GFAP, which lead to protein aggregation and a primary astrocytopathy. Symptoms vary, but failure to thrive (FTT) and frequent emesis are common and cause significant morbidity. Here we investigate GDF15, a member of the
Tracy L. Hagemann, Michelle M. Sonsalla, Cora Luzinski, Fernando Zacahua, David A. Harris, Dudley W. Lamming, Albee Messing   +6 more
wiley   +1 more source

Papel do ecocardiograma na avaliação ventricular do coração transplantado versus rejeição cardíaca Role of echocardiography in the ventricular assessment of the transplanted heart versus heart rejection

Arquivos Brasileiros de Cardiologia, 2012
FUNDAMENTO: O Transplante Cardíaco (TC) é uma alternativa para os indivíduos com doença cardíaca terminal. Na evolução pós-transplante, a ocorrência de episódios de Rejeição Cardíaca (RC) é evento frequente que aumenta a morbimortalidade, sendo ...
Gabriel Antonio Stanisci Miguel, Salomón Soriano Ordinola Rojas, Reinaldo Wilson Vieira, José Pedro da Silva, Henry Abensur   +4 more
doaj  

Infarct tissue characterization in implantable cardioverter-defibrillator recipients for primary versus secondary prevention following myocardial infarction: a study with contrast-enhancement cardiovascular magnetic resonance imaging [PDF]

, 2012
Knowledge about potential differences in infarct tissue characteristics between patients with prior life-threatening ventricular arrhythmia versus patients receiving prophylactic implantable cardioverter-defibrillator (ICD) might help to improve the ...
Birgelen, C. von, Es, J. van, Galjee, M.A., Kraaier, K., Olimulder, M.A.G.M., Palen, J.A.M. van der, Scholten, M.F., Wagenaar, L.J.   +7 more
core   +3 more sources

Scoliosis Surgery in a Patient With Advanced Friedreich's Ataxia—It Is Not Too Late

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Friedreich's ataxia is a multisystem disorder with scoliosis being the most common non‐neurological manifestation. While scoliosis surgery is typically performed in adolescent, ambulatory patients, few data exist on surgical outcomes in patients with advanced disease.
Kathrin Reetz, Stella A. Lischewski, Jörg B. Schulz, Maximilian Praster, Miguel Pishnamaz, on behalf of the FACROSS study group, Imis Dogan, Sandro Romanzetti, Ravi Dadsena, Kerstin Konrad, Thomas Clavel, Vera Jankowski, Joachim Jankowski, Oliver Pabst, Nikolaus Marx, Julia Moellmann, Malte Jacobsen, Katharina Marx‐Schütt, Juergen Dukart, Simon Eickhoff, Ralf‐Dieter Hilgers   +20 more
wiley   +1 more source